0001209191-17-002652.txt : 20170106
0001209191-17-002652.hdr.sgml : 20170106
20170106162839
ACCESSION NUMBER: 0001209191-17-002652
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170104
FILED AS OF DATE: 20170106
DATE AS OF CHANGE: 20170106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Minerva Neurosciences, Inc.
CENTRAL INDEX KEY: 0001598646
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260784194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 284
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-600-7373
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 284
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levine Mark S.
CENTRAL INDEX KEY: 0001617236
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36517
FILM NUMBER: 17514577
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 284
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-04
0
0001598646
Minerva Neurosciences, Inc.
NERV
0001617236
Levine Mark S.
C/O MINERVA NEUROSCIENCES, INC.
1601 TRAPELO ROAD, SUITE 284
WALTHAM
MA
02451
0
1
0
0
SVP,General Counsel & Sec.
Common Stock
2017-01-04
4
M
0
17250
4.71
A
17250
D
Common Stock
2017-01-04
4
M
0
250
5.19
A
17500
D
Common Stock
2017-01-04
4
S
0
17500
12.00
D
0
D
Stock Option (Right to Buy)
4.71
2017-01-04
4
M
0
17250
0.00
D
2025-12-03
Common Stock
17250
51750
D
Stock Option (Right to Buy)
5.19
2017-01-04
4
M
0
250
0.00
D
2025-04-13
Common Stock
250
57274
D
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016.
This option vests as follows: 25% on December 4, 2016 and then in quarterly installments over 3 years thereafter.
This option vests as follows: 25% on April 14, 2016; and then in quarterly installments over 3 years thereafter.
/s/ Mark Levine
2017-01-06